In this study, we aimed to optimize 3′ trans-splicing for the CTNNB1 gene that could correct most reported mutations that cause CTNNB1 syndrome (Figure 1A) while maintaining the endogenous transcriptional regulation. The gene discussed is CTNNB1; the disease is severe intellectual disability-progressive spastic diplegia syndrome.